PTC Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 937.82 million compared to USD 698.8 million a year ago. Net loss was USD 626.6 million compared to USD 559.02 million a year ago.

Basic loss per share from continuing operations was USD 8.37 compared to USD 7.79 a year ago.